Insider filing · SVRA

David A Ramsay bought $288K of Savara (SVRA)

Executed Nov 18 2024, disclosed Nov 18 2024, the same day.

Over the 21 trading sessions from the disclosed entry session (Nov 18 2024), the stock returned +9.2% (delay-adjusted); from the execution session (Nov 18 2024), +9.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

DR David A Ramsay Director profile →

David A Ramsay (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Savara Inc. (SVRA). The largest single filing was $121K of SVRA (20,000 sh × $6.06, as filed), executed Dec 19 2025.

SVRA Savara Inc. SVRA · Healthcare · 5 filings in 24 months ticker →

Healthcare · Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→